N. Aygün Kocabaş Et Al. , "Do CYP2A6 and GSTM1 genotypes have any impact on genotoxicity in Healthy Turkish Smokers?," Fabad Journal of Pharmaceutical Sciences , vol.30, no.1, pp.17-25, 2005
Aygün Kocabaş, N. Et Al. 2005. Do CYP2A6 and GSTM1 genotypes have any impact on genotoxicity in Healthy Turkish Smokers?. Fabad Journal of Pharmaceutical Sciences , vol.30, no.1 , 17-25.
Aygün Kocabaş, N., Karahalil, B., & ÇOK, İ., (2005). Do CYP2A6 and GSTM1 genotypes have any impact on genotoxicity in Healthy Turkish Smokers?. Fabad Journal of Pharmaceutical Sciences , vol.30, no.1, 17-25.
Aygün Kocabaş, NESLİHAN, BENSU KARAHALİL, And İSMET ÇOK. "Do CYP2A6 and GSTM1 genotypes have any impact on genotoxicity in Healthy Turkish Smokers?," Fabad Journal of Pharmaceutical Sciences , vol.30, no.1, 17-25, 2005
Aygün Kocabaş, NESLİHAN A. Et Al. "Do CYP2A6 and GSTM1 genotypes have any impact on genotoxicity in Healthy Turkish Smokers?." Fabad Journal of Pharmaceutical Sciences , vol.30, no.1, pp.17-25, 2005
Aygün Kocabaş, N. Karahalil, B. And ÇOK, İ. (2005) . "Do CYP2A6 and GSTM1 genotypes have any impact on genotoxicity in Healthy Turkish Smokers?." Fabad Journal of Pharmaceutical Sciences , vol.30, no.1, pp.17-25.
@article{article, author={NESLİHAN AYGÜN KOCABAŞ Et Al. }, title={Do CYP2A6 and GSTM1 genotypes have any impact on genotoxicity in Healthy Turkish Smokers?}, journal={Fabad Journal of Pharmaceutical Sciences}, year=2005, pages={17-25} }